---
title: "Meinian Onehealth has established a new medical testing laboratory company in Chengdu"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/256299987.md"
description: "According to the Qichacha APP, recently, Chengdu Meinian Medical Laboratory Co., Ltd. was established with a registered capital of 10 million yuan. The business scope includes: inspection and testing services; operation of Class III medical devices; development of human genetic diagnosis and treatment technology; information system integration services, etc. Qichacha's equity penetration shows that the company is wholly owned by Meinian Onehealth indirectly"
datetime: "2025-09-08T01:45:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/256299987.md)
  - [en](https://longbridge.com/en/news/256299987.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/256299987.md)
generator: "portal-rs"
---

# Meinian Onehealth has established a new medical testing laboratory company in Chengdu

According to the Qichacha APP, recently, Chengdu Meinian Medical Laboratory Co., Ltd. was established with a registered capital of 10 million yuan. The business scope includes: inspection and testing services; operation of Class III medical devices; development of human genetic diagnosis and treatment technology; information system integration services, etc. Qichacha's equity penetration shows that the company is wholly owned by Meinian Onehealth indirectly

### Related Stocks

- [002044.CN](https://longbridge.com/en/quote/002044.CN.md)

## Related News & Research

- [Why the jobs report will actually be good for bonds](https://longbridge.com/en/news/298066649.md)
- [08:36 ETNelson-Jameson Earns Prestigious 2026 Well Workplace Gold Award](https://longbridge.com/en/news/297787452.md)
- [Entertainment platform aTwist launches with microseries as Hollywood chases mobile viewers](https://longbridge.com/en/news/297894583.md)
- [U.S. job openings rise to 7.271 million in July](https://longbridge.com/en/news/297664395.md)
- [CSPC’s SYS6010 Wins Third Breakthrough Therapy Tag in High-Need Cancer Indications](https://longbridge.com/en/news/297638498.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**